AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 184 filers reported holding AXSOME THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.99 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $25,288,000 | +9.6% | 610,970 | 0.0% | 0.14% | +29.5% |
| Q4 2021 | $23,082,000 | +29.9% | 610,970 | +13.3% | 0.11% | +43.6% |
| Q3 2021 | $17,767,000 | -51.1% | 539,057 | 0.0% | 0.08% | -51.2% |
| Q2 2021 | $36,365,000 | +2.2% | 539,057 | -14.2% | 0.16% | +3.9% |
| Q1 2021 | $35,581,000 | -43.9% | 628,414 | -19.3% | 0.15% | -35.6% |
| Q4 2020 | $63,452,000 | -7.2% | 778,834 | -18.9% | 0.24% | -12.5% |
| Q3 2020 | $68,383,000 | -17.7% | 959,757 | -5.0% | 0.27% | -25.4% |
| Q2 2020 | $83,083,000 | +58.7% | 1,009,757 | +13.5% | 0.37% | +13.7% |
| Q1 2020 | $52,344,000 | -39.0% | 889,757 | +7.2% | 0.32% | -29.4% |
| Q4 2019 | $85,764,000 | +448.7% | 829,757 | +7.4% | 0.46% | +330.2% |
| Q3 2019 | $15,631,000 | -21.4% | 772,286 | 0.0% | 0.11% | -21.5% |
| Q2 2019 | $19,886,000 | +16.5% | 772,286 | -35.6% | 0.14% | +23.9% |
| Q1 2019 | $17,076,000 | – | 1,200,000 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 758,794 | $53,032,113 | 65.14% |
| Fairmount Funds Management LLC | 2,341,238 | $163,629,124 | 19.69% |
| Ally Bridge Group (NY) LLC | 110,600 | $7,729,834 | 9.07% |
| RTW INVESTMENTS, LP | 4,489,596 | $313,777,864 | 6.62% |
| SVB FINANCIAL GROUP | 33,849 | $2,365,707 | 4.45% |
| BVF INC/IL | 2,131,100 | $148,942,579 | 4.02% |
| Altium Capital Management LP | 92,000 | $6,429,880 | 3.35% |
| Tri Locum Partners LP | 142,510 | $9,960,024 | 3.18% |
| TANG CAPITAL MANAGEMENT LLC | 320,000 | $22,364,800 | 3.16% |
| Deep Track Capital, LP | 1,140,745 | $79,726,668 | 3.08% |